About J-GLOBAL

日本語

Font size
  • A
  • A

Articleの詳細情報

ArticleJ-GLOBAL ID:200902131042667012整理番号:97A0900640

高脂血症治療薬ゲムフィブロジルの第I相臨床試験 成人男子志願者を対象とした1,200mg/日4週間投与試験

A Phase I Study of an Anti-hyperlipemic Agent, Gemfibrozil. A 4-week Treatment with 1,200mg/day in Adult Male Volunteers.

著者:中谷矩章(東海大 医 東京病院)、五島雄一郎(東海大 医)
資料名:臨床医薬 巻:13 号:14 ページ:3601-3622
発行年:1997年09月
  • J-GLOBAL home
  • Bookmark J-GLOBAL

J-GLOBAL: Linking, Expanding and Sparking

About J-GLOBAL

Linking

J-GLOBAL links information that represents the key to research and development. For example, linking articles and patents with people (authors and inventors) enables the extraction of a sequence of information.
It’s useful for making new discoveries and uncovering new information.

Expanding

The system enables searches of similar kinds of content through linkage with external sites.
It helps you to obtain knowledge from dissimilar fields and discover concepts that cross the boundaries of specialisms.

Sparking

Through repeated linkage and expansioniteration, J-GLOBAL provides unexpected hints for problem-solving and the illumination of new ideas.